McKesson is acquiring US Oncology in a deal valued at $2.16 billion. The combined organization will focus on providing a comprehensive offering of solutions for the oncology industry, they stated. “The unified organization will bring together the collective capabilities of McKesson and US Oncology to provide oncology customers access to: Leading evidence-based medicine offerings that drive continued improvements in clinical outcomes and enable value-based reimbursement; Expanded clinical expertise, clinical research and personalized medicine offerings;